Inorganic nanoparticles as carriers for efficient cellular delivery
Introduction
Cellular delivery involving the transfer of various drugs and bio-active molecules (peptides, proteins and DNAs, etc.) through the cell membrane into cells has attracted increasing attention because of its importance in medicine and drug delivery. This topic has been extensively reviewed (Heiser, 2004, Azzam and Domb, 2004, Dietz and Bahr, 2004, Langer and Peppas, 2003, Rolland, 1999, Garnett, 2004). The direct delivery of drugs and biomolecules, however, is generally inefficient and suffers from problems such as enzymic degradation of DNAs (Heiser, 2004, Garnett, 2004). Therefore, searching for efficient and safe transport vehicles (carriers) to delivery biomolecules and drugs into cells has been challenging yet exciting area of research. Virus is an excellent example in nature that transfers into the targeted cells very efficiently. It is also known for a long time that polybasic peptides like poly(lysine) highly enhance the protein uptake, and based on these, an omnipotent and marvelous carrier, i.e., Trojan Horse was designed which can carry the desired drugs, proteins or DNAs cross the cell membrane efficiently (Dietz and Bahr, 2004).
In past decades, many carriers have been developed and investigated extensively (Azzam and Domb, 2004, Garnett, 2004), and can be generally classified into four major groups: viral carriers, organic cationic compounds, recombinant proteins and inorganic nanoparticles. In viral carriers, part of original gene segment is eliminated to leave space for the gene to be inserted and delivered. Carriers consisting of cationic compounds mainly include cationic lipids, cationic polysaccharides, polycationic polymers, where the positive charges are resulted from protonation of various amino/imino groups. A particular type of DNA vectors receiving attention recently is recombinant proteins (Aris and Villlaverde, 2004). These proteins mimic the various viral properties by combining diverse peptide segments that are required for efficient gene delivery into a single molecule through protein engineering. For example, the multifunctional proteins may include polylysine segments, protamine, histones and amphipathic cationic peptides to bind DNA to form thermodynamically stable complexes. They may also contain antibodies, antibody segments for targeting cell delivery and some short peptide sequences acting as nuclear localisation signals. Although the formation of vector-DNA complexes is similar to the normal cationic compounds, protein vectors are much more biocompatible. Inorganic nanoparticles as new non-viral carriers have attracted much attention only recently. Many inorganic materials, such as calcium phosphate, gold, carbon materials, silicon oxide, iron oxide and layered double hydroxide (LDH), have been studied. The four types of carriers are briefly compared in Table 1. In summary, viral carriers are to date the most effective, but severe side effects (e.g. immune response and insertional mutagenesis) limit the successful application in cellular delivery. Cationic carriers (lipids and polymers) may avoid such problems but are often toxic to the cells. In contrast, inorganic nanoparticles show low toxicity and promise for controlled delivery properties, thus presenting a new alternative to viral carriers and cationic carriers. However, it is noted that the cellular transfer efficiency with existing inorganic nanoparticles is relatively low at this stage.
Inorganic nanoparticles generally possess versatile properties suitable for cellular delivery, including wide availability, rich functionality, good biocompatibility, potential capability of targeted delivery (e.g. selectively destroying cancer cells but sparing normal tissues) and controlled release of carried drugs. This is why increasing efforts in research and development worldwide have been devoted to various inorganic materials as novel non-viral carriers in the last decade (Ozkan, 2004, Barbe et al., 2004, Bauer et al., 2004). The present review aims to examine the latest advances in inorganic nanoparticle applications as cellular delivery carriers and highlight some of the key issues in efficient cellular delivery using inorganic nanoparticles. Critical properties of inorganic nanoparticles, surface functionalisation (modification), uptake of biomolecules, the driving forces for delivery, and release of biomolecules will be reviewed systematically in Section 2. Section 3 will present selected examples of promising inorganic nanoparticle delivery systems, including gold, fullerenes and carbon nanotubes (CNTs), LDH and various oxide nanoparticles in particular their applications for gene delivery. The fundamental understanding of properties of inorganic nanoparticles in relation to cellular delivery efficiency is the most paramount issue which will be highlighted in Section 4.
To avoid possible confusion in some terminologies, we present the following basic definitions and terminologies for the convenience of the readers. Nanoparticles generally refer to particles with diameters ranging from 1 to a few 100 nm. Functionalised inorganic nanoparticles with or without biomolecules loaded are generally described as hybrid nanoparticles, organic/inorganic nanohybrids or simply nanohybrids. In addition, carriers, vectors and agents in the content of this paper all refer to the vehicles that are used to carry drugs and biomolecules for cellular delivery.
Section snippets
Properties and bio-interactions of inorganic nanoparticles
To aid our understanding of the fundamental surface properties, and functionalisation of nanoparticles and their bio-interactions, it is useful to conceptualise some generic scenarios of nanoparticles and biomolecular interactions. Fig. 1 is a schematic representation of surface-functionalised inorganic nanoparticles (also refer to Table 2), and the processes of biomolecule uptake and the cellular transfer pathways. The critical factors that affect the transfection efficiency and effectiveness
Gold and other metal nanoparticles
Metal nanoparticles (including nanospheres, nanoshells and nanorods) have been evaluated for target cellular delivery. Gold nanoparticles in particular are an excellent intracellular targeting vector because: (1) they can be easily tailored to a desirable size from 0.8 and 200 nm; (2) their surface can be modified to impart various functionalities and good biocompatibility; (3) they possess visible light extinction behaviour, which makes it possible to track nanoparticle trajectories in the
Availability and particle size
All of the inorganic nanoparticles discussed in the previous sections are either commercialised or can be readily prepared in laboratory. For example, silica suspensions and fullerenes are available from various chemical companies. LDH and iron magnetic nanoparticles can be readily synthesised with a well controlled particle size. As mentioned previously, the size of inorganic nanoparticles can range from 1 to 200 nm (Table 2). After appropriate modifications, the size of hybrid nanoparticles
Concluding remarks and perspectives
There have been an increasing number of inorganic nanoparticles that have been studied as drug (gene) delivery carriers, because of their versatile physicochemical properties. Inorganic nanoparticles are readily available, can be easily functionalised, and possess good biocompatibility and low cytotoxicity, as summarised in Table 2. It is evident that the versatility of inorganic nanoparticles makes them very suitable as potential delivery carriers. However, the transfection efficiency of these
References (72)
- et al.
Modular protein engineering for non-viral gene delivery
Trends in Biotechnology
(2004) - et al.
Dextran and albumin derivatized iron oxide nanoparticles: influence on fibroblasts in intro
Biomaterials
(2003) - et al.
High-efficiency gene delivery for expression in mammalian cells by nanoprecipitates of Ca-Mg phosphate
Gene
(2004) - et al.
Delivery of bioactive molecules into the cell: the Trojan horse approach
Molecular and Cellular Neuroscience
(2004) - et al.
Cellular, localisation of a water-soluble fullerene derivative
Biochemical and Biophysical Research Communications
(2002) - et al.
A new technique for the assay of infectivity of human adenovirus 5 DNA
Virology
(1973) - et al.
Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors
Biomaterials
(2004) - et al.
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles
Biomaterials
(2005) - et al.
Synthesis and surface engineering of iron oxide nanoparticles for biological applications
Biomaterials
(2005) - et al.
Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA
International Journal of Pharmaceutical
(2000)